Skip to main content
Premium Trial:

Request an Annual Quote

Microarrays Inc. Expands into European Market with Three Distribution Deals


By Justin Petrone

Microarrays Inc. last week announced distribution agreements with several companies, expanding its commercial activities for the first time into various European markets.

The Huntsville, Ala.-based firm has tapped Cambio to distribute its products in the UK and Ireland; BioCat to cover Germany, Austria, and Switzerland; and Biosolutions to sell its arrays to customers in Cyprus, Greece, and other Balkan countries.

The trio of firms will serve as exclusive distributors for MI products and services, including MI's custom arrays for the biological research, detection, and diagnostics markets, the company said.

Andrew Jennings, the firm's president of business development, said in a statement that MI is counting on its partners' "knowledge of the local biotechnology landscape" to "drive its growth in Europe."

Founded in 1999, MI has its origins in the Microarray Core facility of the Vanderbilt-Ingram Comprehensive Cancer Center in Nashville, Tenn. The firm was established as an autonomous company in November 2000 and relocated to the HudsonAlpha Institute for Biotechnology in Huntsville eight years later. MI has been privately held since May 2010 (BAN 7/20/2010).

The firm offers catalog and custom DNA, protein, antibody, and small-molecule arrays. It also offers array assay development services.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.